Online course promotions suggest you can even learn rocket science from your bedroom or be a doctor by studying only via YouTube - but is that truly realistic?
Newspoint on MSN
Online degree rules: After class 12, do not—under any circumstances—pursue these online course...
Online Degree Rules: Since the onset of the COVID-19 era, the world has grown accustomed to working and studying from home.
Lucknow University raises PG application fees for 2026-27: +50% for general courses, +25% for professional programmes; some course fees up 20%-85%.
Newspoint on MSN
Not just engineering and medicine: These 10 courses after class 12 also offer fantastic career prospects
Top 10 Courses After Class 12: Do you want to build a career that stands out from the crowd after completing Class 12?
Pic: Police and Food Department officials on Friday seized over 150 tonnes of Anna Bhagya scheme rice stocked illegally in an ...
What the Padres have done at or near the end of several games is impressive, but Manny Machado keeping it real about team’s ...
Massachusetts biotech Replimune laid off more than 200 employees Friday after the Food and Drug Administration doubled down on its rejection of the company’s treatment for advanced skin cancer. The ...
A Woburn biotechnology company is set to lay off dozens of Massachusetts employees after federal regulators rejected its lead cancer treatment for the second time. According to a Worker Adjustment and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company informed the state ...
Gossamer Bio is picking up the pieces after failing to bring its only late-stage drug to market. The local biotech plans to lay off 65 San Diegans, almost half of its total workforce. While the ...
China-based Xiamen Kang Zhongyuan Biotechnology recalled certain cough drops in the U.S. in connection with Food and Drug Administration observations during a manufacturing-facility inspection "that ...
While the company — focused on treating a rare lung disease — has other drugs in the pipeline, the question remains whether Gossamer has the money and manpower to continue with the costly trials. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results